Passage Bio, Inc.PASGNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P71
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 202511.00%
Q3 202516.25%
Q2 202537.21%
Q1 2025-15.34%
Q4 202431.07%
Q3 2024-19.13%
Q2 20243.72%
Q1 20242.15%
Q4 202335.67%
Q3 2023-12.94%
Q2 202329.25%
Q1 2023-27.05%
Q4 2022-2.61%
Q3 202230.86%
Q2 20227.01%
Q1 202216.32%
Q4 2021-8.62%
Q3 20212.95%
Q2 2021-24.66%
Q1 20210.31%
Q4 2020-36.42%
Q3 2020-4.86%
Q2 2020-52.43%
Q1 2020-31.78%
Q4 2019-16.74%
Q3 2019-49.90%
Q2 2019-85.50%
Q1 201934.80%
Q4 20180.00%